Itraconazole

Itraconazole is a triazole antifungal agent with a broad spectrum of activity against dermatophytes, yeasts, and molds. It inhibits fungal CYP450-dependent lanosterol demethylase. Mediocon Inc supplies high-purity Itraconazole API meeting IP/BP/EP/USP standards for oral and topical formulations.

Key Features

• Broad-spectrum triazole antifungal
• IP/BP/EP/USP compliant quality
• Effective against dermatophytes, yeasts, molds
• Available in micronized form for better bioavailability

Applications

• Systemic fungal infections (aspergillosis, candidiasis)
• Onychomycosis (nail fungal infections)
• Dermatophytosis
• Blastomycosis and histoplasmosis

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings